Identification |
Name: | Ethanol,2-[[9-methyl-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]- |
Synonyms: | 2-(2-Hydroxyethylamino)-6-(benzylamino)-9-methylpurine;2-(2'-Hydroxyethylamino)-9-methyl-6-(benzylamino)purine;6-(Benzylamino)-2-(2-hydroxyethylamino)-9-methylpurine;NSC 666096; |
CAS: | 101622-51-9 |
Molecular Formula: | C15H18N6O |
Molecular Weight: | 298.34302 |
InChI: | InChI=1S/C15H18N6O/c1-21-10-18-12-13(17-9-11-5-3-2-4-6-11)19-15(16-7-8-22)20-14(12)21/h2-6,10,22H,7-9H2,1H3,(H2,16,17,19,20) |
Molecular Structure: |
|
Properties |
Transport: | HAZARD |
Density: | 1.36 g/cm3 |
Refractive index: | 1.69 |
Water Solubility: | Insoluble (soluble in methanol, DMSO |
Solubility: | Insoluble (soluble in methanol, DMSO |
Appearance: | white crystalline powder |
Specification: |
1.General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
2.Extinguishing Media: Use water spray, dry chemical, carbon dioxide, or chemical foam.
3.Handling: Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
4.Storage: Store Olomoucin (CAS NO. 101622-51-9) in a cool, dry place. Store in a tightly closed container. Deep freeze (below -20°C).
|
Biological Activity: | Cyclin-dependent kinase inhibitor that competes for the ATP binding site of the kinase. Selectively inhibits cdc2/cyclin B (IC 50 = 7 μ M), cdk2/cyclin A (IC 50 = 7 μ M), cdk2/cyclin E (IC 50 = 7 μ M), cdk/p35 kinase (IC 50 = 3 μ M)? and ERK1/MAP kinase (IC 50 = 25 μ M). Arrests human fibroblasts in the G1 phase. |
Storage Temperature: | −20°C |
Usage: |
Olomoucin (CAS NO. 101622-51-9) is a purine derivative which inhibits cyclin-dependent kinases and induces G1 arrest .
|
Safety Data |
Hazard Symbols |
|
|
|